Unknown

Dataset Information

0

Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV.


ABSTRACT: Human immunodeficiency virus (HIV) is an attractive target for chimeric antigen receptor (CAR) therapy. CAR T cells have proved remarkably potent in targeted killing of cancer cells, and we surmised that CAR T cells could prove useful in eradicating HIV-infected cells. Toward this goal, we interrogate several neutralizing single-chain variable fragments (scFvs) that target different regions of the HIV envelope glycoprotein, gp120. We find here that CAR T cells with scFv from NIH45-46 antibody demonstrated the highest cytotoxicity. Although NIH45-46 CAR T cells are capable of eliminating antigen-expressing cells, we wanted to address HIV reactivation from ex vivo culture of HIV patient-derived CAR T cells. In order to capitalize on the HIV reactivation, we developed a conditionally replicating lentiviral vector (crLV). The crLV can hijack HIV machinery, forming a chimeric lentivirus (LV) instead of HIV and delivered to uninfected cells. We find that CAR T cells generated with crLVs have similar CAR-mediated functionality as traditional CARs. We also demonstrate crLVs' capability of expanding CAR percentage and protecting CD4 CAR T cell in HIV donors. Collectively, we demonstrate here that the novel crLV NIH45-46 CAR can serve as a strategy to combat HIV, as well as overcome HIV reactivation in CD4+ CAR T cells.

SUBMITTER: Urak RZ 

PROVIDER: S-EPMC7569266 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV.

Urak Ryan Z RZ   Soemardy Citradewi C   Ray Roslyn R   Li Shirley S   Shevchenko Galina G   Scott Tristan T   Lim Laura L   Wang Xiuli X   Morris Kevin V KV  

Molecular therapy. Methods & clinical development 20200928


Human immunodeficiency virus (HIV) is an attractive target for chimeric antigen receptor (CAR) therapy. CAR T cells have proved remarkably potent in targeted killing of cancer cells, and we surmised that CAR T cells could prove useful in eradicating HIV-infected cells. Toward this goal, we interrogate several neutralizing single-chain variable fragments (scFvs) that target different regions of the HIV envelope glycoprotein, gp120. We find here that CAR T cells with scFv from NIH45-46 antibody de  ...[more]

Similar Datasets

| S-EPMC3486895 | biostudies-literature
| S-EPMC9585667 | biostudies-literature
| S-EPMC6008046 | biostudies-literature
| S-EPMC7399702 | biostudies-literature
| S-EPMC10773964 | biostudies-literature
| S-EPMC7158672 | biostudies-literature
| S-EPMC6330382 | biostudies-literature
| S-EPMC6411696 | biostudies-literature
| S-EPMC2980466 | biostudies-literature
| S-EPMC6410718 | biostudies-literature